| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.700 | None | 0.939 | 59 | 8 | 2007 | 2020 | |||||||||
|
inflammatory bowel disease 5 | 0.705 | 0.538 |
|
disease | 0.100 | None | 0.913 | 44 | 0 | 2001 | 2012 | |||||||||
|
H3 histone pseudogene 28 | 0.553 | 0.692 |
|
disease | 0.100 | None | 0.882 | 17 | 0 | 1998 | 2020 | |||||||||
|
inflammatory bowel disease 3 | 0.861 | 0.038 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2002 | 2014 | |||||||||
|
microRNA 31 | 0.471 | 0.769 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2013 | 2019 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1996 | 2018 | |||||||||
|
KLRC4-KLRK1 readthrough | 0.469 | 0.769 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2011 | 2017 | |||||||||
|
H3 histone pseudogene 13 | 0.584 | 0.769 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2013 | 2019 | |||||||||
|
inflammatory bowel disease 2 | 0.805 | 0.154 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2000 | 2005 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1998 | 2018 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1998 | 2018 | |||||||||
|
inflammatory bowel disease 6 | 0.861 | 0.077 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2003 | 2015 | |||||||||
|
CD24 molecule | 0.472 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2011 | 2015 | |||||||||
|
defensin alpha 1 | 0.636 | 0.731 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2018 | |||||||||
|
prostate androgen-regulated transcript 1 | 0.483 | 0.885 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | |||||||||
|
microRNA 122 | 0.468 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2016 | 2019 | |||||||||
|
microRNA 19b-1 | 0.529 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2015 | 2019 | |||||||||
|
inflammatory bowel disease 4 | 0.890 | 0.077 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2018 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2018 | |||||||||
|
H3 clustered histone 9, pseudogene | 0.656 | 0.538 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2000 | |||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 2605 | 0.490 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2020 | |||||||||
|
major histocompatibility complex, class II, DR beta 3 | 0.570 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1996 | 1998 | |||||||||
|
long intergenic non-protein coding RNA 1193 | 0.565 | 0.692 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2014 |